Enhanced Efficacy of a Codon-Optimized DNA Vaccine Encoding the Glycoprotein Precursor Gene of Lassa Virus in a Guinea Pig Disease Model When Delivered by Dermal Electroporation
Lassa virus (LASV) causes a severe, often fatal, hemorrhagic fever endemic to West Africa. Presently, there are no FDA-licensed medical countermeasures for this disease. In a pilot study, we constructed a DNA vaccine (pLASV-GPC) that expressed the LASV glycoprotein precursor gene (GPC). This plasmid...
Main Authors: | Niranjan Y. Sardesai, Connie S. Schmaljohn, Catherine V. Badger, Mary C. Guttieri, Kristin W. Spik, Carl I. Shaia, Amy C. Shurtleff, Todd M. Bell, Kate E. Broderick, Eric R. Wilkinson, Kathleen A. Cashman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2013-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | http://www.mdpi.com/2076-393X/1/3/262 |
Similar Items
-
A Lassa Fever Live-Attenuated Vaccine Based on Codon Deoptimization of the Viral Glycoprotein Gene
by: Yingyun Cai, et al.
Published: (2020-02-01) -
Lassa Fever: Viral Replication, Disease Pathogenesis, and Host Immune Modulations
by: Hinh Ly
Published: (2020-06-01) -
Lassa fever: History, causes, effects, and reduction strategies
by: Promise Tewogbola, et al.
Published: (2020-08-01) -
Mastomys natalensis and Lassa Fever, West Africa
by: Emilie Lecompte, et al.
Published: (2006-12-01) -
Animal Models of Lassa Fever
by: Rachel A. Sattler, et al.
Published: (2020-03-01)